Biogen Idec appoints Spyros Artavanis-Tsakonas chief scientific officer Chris Reidy May 23, 2013 Spyros Artavanis-Tsakonas, HMS professor of cell biology, has been appointed to the post of chief scientific officer of Biogen Idec Inc., the Weston biotechnology company perhaps best known for its multiple sclerosis drugs announced. Read full article
Are We on the Cusp of a Major Bird Flu Outbreak? March 7, 2025 Scientists weigh in on the spread of H5N1 and highlight clues that portend what might come next
Creating the World’s First CRISPR Medicine, for Sickle Cell Disease February 20, 2025 How a genetic insight paired with gene editing technology led to a life-changing new therapy
Meet Two of the Researchers Selected by the Pope To Promote Science May 5, 2025 Members of Pontifical Academy of Sciences share hopes for improving human health